Alopecia areata is a non-scarring form of alopecia that can be localized or widespread. Its etiology is unknown, but immunological factors are implicated in its pathogenesis. With the more frequent use of anti TNFα biologic drugs, some alopecia areata cases during their use have been described. We report a case of universal alopecia in a patient with rheumatoid arthritis while using adalimumab and leflunomide
Alopecia areata is a common autoimmune disorder that targets hair follicles. Swarms of lymphocytes s...
AbstractAdalimumab is a fully human immunoglobulin G1 monoclonal antibody against tumor necrosis fac...
Repigmentation of canities, or age-related grey or white hair, is a rare occurrence. Generalized rep...
Adalimumab is a fully humanized recombinant anti-tumour-necrosis-factor (TNF-alpha) monoclonal antib...
Secondary autoimmunity is the most frequent adverse event occurring in almost every other alemtuzuma...
Alopecia Universalis (AU) is the most severe form of Alopecia Areata and is caused by cytotoxic T-ce...
Cytotoxic T-lymphocyte-associated protein-4, programmed cell death protein and programmed cell death...
Alopecia areata (AA) is considered an autoimmune disease targeted at hair follicles with T-lymphocyt...
Alopecia universalis is an uncommon form of alopecia areata involving hair loss over the entire scal...
Immune checkpoint modulators are becoming more prevalent in clinical use for the treatment of metast...
Alopecia areata (AA) is a chronic autoimmune disease that causes non-scarring alopecia. While most c...
Adalimumab is a fully human immunoglobulin G1 monoclonal antibody against tumor necrosis factor (TNF...
Alopecia Universalis (AU) is the most severe form of Alopecia Areata and is caused by cytotoxic T-ce...
Alopecia areata is a common autoimmune disorder that targets hair follicles. Swarms of lymphocytes s...
Alopecia universalis (AU) is generally considered a variant of alopecia areata (AA), in which the tr...
Alopecia areata is a common autoimmune disorder that targets hair follicles. Swarms of lymphocytes s...
AbstractAdalimumab is a fully human immunoglobulin G1 monoclonal antibody against tumor necrosis fac...
Repigmentation of canities, or age-related grey or white hair, is a rare occurrence. Generalized rep...
Adalimumab is a fully humanized recombinant anti-tumour-necrosis-factor (TNF-alpha) monoclonal antib...
Secondary autoimmunity is the most frequent adverse event occurring in almost every other alemtuzuma...
Alopecia Universalis (AU) is the most severe form of Alopecia Areata and is caused by cytotoxic T-ce...
Cytotoxic T-lymphocyte-associated protein-4, programmed cell death protein and programmed cell death...
Alopecia areata (AA) is considered an autoimmune disease targeted at hair follicles with T-lymphocyt...
Alopecia universalis is an uncommon form of alopecia areata involving hair loss over the entire scal...
Immune checkpoint modulators are becoming more prevalent in clinical use for the treatment of metast...
Alopecia areata (AA) is a chronic autoimmune disease that causes non-scarring alopecia. While most c...
Adalimumab is a fully human immunoglobulin G1 monoclonal antibody against tumor necrosis factor (TNF...
Alopecia Universalis (AU) is the most severe form of Alopecia Areata and is caused by cytotoxic T-ce...
Alopecia areata is a common autoimmune disorder that targets hair follicles. Swarms of lymphocytes s...
Alopecia universalis (AU) is generally considered a variant of alopecia areata (AA), in which the tr...
Alopecia areata is a common autoimmune disorder that targets hair follicles. Swarms of lymphocytes s...
AbstractAdalimumab is a fully human immunoglobulin G1 monoclonal antibody against tumor necrosis fac...
Repigmentation of canities, or age-related grey or white hair, is a rare occurrence. Generalized rep...